You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金河生物(002688.SZ):美國為最大的海外市場,約佔外銷的三分之二左右
格隆匯 05-16 15:14

格隆匯5月16日丨金河生物(002688.SZ)在投資者互動平台表示,經過三十多年的發展,公司建立了全球化的業務佈局。獸用化藥業務方面:1994年公司首次通過了美國FDA的質量驗收,截至目前,公司已連續八次通過美國FDA認證。公司相關產品也取得了歐洲藥品質量管理局(EDQM)簽發的CEP證書認證。公司產品暢銷海外市場,包括美國、東南亞、印度、越南、加拿大、墨西哥、巴西、阿根廷、澳大利亞、歐洲等國家和地區。從銷量來看,獸用化藥出口佔比60%-70%,美國為最大的海外市場,約佔外銷的三分之二左右。公司獸用疫苗銷售市場涵蓋國內和國外市場。美國疫苗生產基地產品銷售至國內、美國、加拿大、墨西哥、哥倫比亞、巴西、阿根廷、挪威、泰國、越南、韓國等國家。2024年,公司業務國內國際市場雙輪驅動,實現了營業收入同比增長。未來,公司將繼續依託全球化佈局、市場及資本整合的優勢,優化資源配置,把握全球動保發展機遇。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account